Patricia A. Cochran

FDA investigator

Appears on 3 documents from 2001, mostly at sites in Indiana. Most often cites control of microbiological contamination (21 CFR 211.113).

3
Documents on file
20.0
Observations per 483
2001
First seen
2001
Most recent

What they cite most

From 20 observations

Activity by year

2001: 3

Where

Indiana 3

Is Patricia A. Cochran coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
Response Eli Lilly and CompanyMar 8, 2001 · Indianapolis, Indiana
Warning letter Eli Lilly and CompanyMar 2, 2001 · Indianapolis, Indiana
483 Eli Lilly and CompanyFeb 23, 2001 · Indianapolis, Indiana

About this profile

What does Patricia A. Cochran inspect?

Patricia A. Cochran appears on 3 documents on file covering 1 site, mostly in Indiana.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.188 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Patricia A. Cochran is dated Mar 8, 2001.